These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8132212)

  • 1. A longitudinal study of per cent agalactosyl IgG in tuberculosis patients receiving chemotherapy, with or without immunotherapy.
    Rook GA; Onyebujoh P; Wilkins E; Ly HM; al Attiyah R; Bahr G; Corrah T; Hernandez H; Stanford JL
    Immunology; 1994 Jan; 81(1):149-54. PubMed ID: 8132212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG response to some mycobacterial antigens in selected leprosy patients.
    Rafi A
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):567-71. PubMed ID: 10437959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raised agalactosyl IgG and antimycobacterial humoral immunity in Takayasu's arteritis.
    Hernández-Pando R; Reyes P; Espitia C; Wang Y; Rook G; Mancilla R
    J Rheumatol; 1994 Oct; 21(10):1870-6. PubMed ID: 7837153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis?
    Stanford JL; Stanford CA; Grange JM; Lan NN; Etemadi A
    Respir Med; 2001 Jun; 95(6):444-7. PubMed ID: 11421500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical study on vaccine of Mycobacterium vaccae in treating pulmonary tuberculosis].
    Wang W; Jin G; Ye Y; Xia X; Wang A; Zhuang Y; Li G; Sun H; Wang Z; Lin M; Chen H; Li J; Dan Z; Zhang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):108-10. PubMed ID: 11820954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agalactosyl IgG and antibody specificity in rheumatoid arthritis, tuberculosis, systemic lupus erythematosus and myasthenia gravis.
    Pilkington C; Yeung E; Isenberg D; Lefvert AK; Rook GA
    Autoimmunity; 1995; 22(2):107-11. PubMed ID: 8722580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma.
    O'Brien ME; Saini A; Smith IE; Webb A; Gregory K; Mendes R; Ryan C; Priest K; Bromelow KV; Palmer RD; Tuckwell N; Kennard DA; Souberbielle BE
    Br J Cancer; 2000 Oct; 83(7):853-7. PubMed ID: 10970684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis].
    Luo Y;
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan; 24(1):43-7. PubMed ID: 11802939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659.
    Stanford JL; Stanford CA
    Immunobiology; 1994 Oct; 191(4-5):555-63. PubMed ID: 7713570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC; Abdulmumini T; Robinson S; Rook GA; Stanford JL
    Respir Med; 1995 Mar; 89(3):199-207. PubMed ID: 7746913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea.
    Azzurri A; Kanaujia GV; Sow OY; Bah B; Diallo A; Del Prete G; Gennaro ML
    Int J Immunopathol Pharmacol; 2006; 19(1):199-208. PubMed ID: 16569358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUTI: a new chance to shorten the treatment of latent tuberculosis infection.
    Cardona PJ
    Tuberculosis (Edinb); 2006; 86(3-4):273-89. PubMed ID: 16545981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of anti-lipoarabinomannan antibodies for the diagnosis of active tuberculosis.
    Del Prete R; Picca V; Mosca A; D'Alagni M; Miragliotta G
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):160-3. PubMed ID: 9562127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytokines in the immunopathology of tuberculosis, and the regulation of agalactosyl IgG.
    Rook GA; Attiyah RA; Foley N
    Lymphokine Res; 1989; 8(3):323-8. PubMed ID: 2674558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune response against mycobacterial antigens in children with tuberculosis.
    Demkow U; Ziołkowski J; Białas-Chromiec B; Filewska M; Zielonka T; Wasik M; Rowińska-Zakrzewska E
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():63-73. PubMed ID: 17072031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.
    Silva CL; Bonato VL; Coelho-Castelo AA; De Souza AO; Santos SA; Lima KM; Faccioli LH; Rodrigues JM
    Gene Ther; 2005 Feb; 12(3):281-7. PubMed ID: 15526006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.